Response monitoring in metastatic breast cancer: a comparison of survival times between FDG-PET/CT and CE-CT.

ABSTRACT:

Background

We compared overall survival for metastatic breast cancer (MBC) patients monitored with CE-CT, FDG-PET/CT or a combination of them in an observational setting.

Methods

Patients with biopsy-verified (recurrent or de novo) MBC (n = 300) who were treated at Odense university hospital (Denmark) and response monitored with FDG-PET/CT (n = 83), CE-CT (n = 144), or a combination of these (n = 73) were followed until 2019. Survival was compared between the scan groups, and were adjusted for clinico-histopathological variables representing potential confounders in a Cox proportional-hazard regression model.

Results

The study groups were mostly comparable regarding baseline characteristics, but liver metastases were reported more frequently in CE-CT group (38.9%) tha

SUBMITTER: Naghavi-Behzad M 

PROVIDER: S-EPMC9042860 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature